Phase II Study of Adavosertib in Patients With Tumors Containing BRCA1 and BRCA2 Mutations: Results From the NCI-MATCH ECOG-ACRIN Cancer Research Group (EAY131) Subprotocol Z1I. - Kummar S; Song Z; Reiss KA; Ford JM; Chen L; Rolig AS; Zwiebel JA; Gore SD; Gray RJ; Wang V; McShane LM; Rubinstein LV; et al. (JCO precision oncology, 2026)